Tag: Advanced Diabetes Supply
In brief: MA payments, tech stage, device risk, Cardinal acquisition
February 2, 2024HME News Staff
WASHINGTON – CMS has released a Calendar Year 2025 Advance Notice for the Medicare Advantage and Medicare Part D Prescription Drug Programs that would pave the way for payments to MA plans to increase on average by 3.7%, or more than $16 billion, from 2024 to 2025.
“CMS continues to ensure that Medicare Advantage and Part D prescription drug plans remain strong, stable and affordable offerings,” said CMS Administrator Chiquita Brooks-LaSure. “The Advance Notice upholds...
ADS adds Libre 2 Plus sensor
January 31, 2024HME News Staff
CARLSBAD, Calif. — Advanced Diabetes Supply (ADS), a national distributor of diabetes devices under the ADS and US MED brands, is now carrying the new FreeStyle Libre 2 Plus sensor, the first DME provider in the country to offer consumers the 15-day sensor. “The FreeStyle Libre 2 Plus is an exciting advancement in diabetes health technology and is the only 15-day non-implantable continuous glucose monitoring (CGM) sensor in the U.S.,” said Bill Mixon, CEO of ADS. “As leading...
In brief: AAH pushes for follow up, StateServ buys PBM, ADS builds C-suite
January 24, 2024HME News Staff
WASHINGTON – The U.S. House of Representatives passed a short-term spending bill on Jan. 18 to keep the government funded until the beginning of March, AAHomecare reports, but the bill does not contain various health care extender measures, including the industry’s provision to extend the 75/25 blended Medicare reimbursement rates in non-rural areas.
“We are continuing to work with our champions, as well as influential legislators and committee staff, to pass our legislation...
Advanced Diabetes Supply builds out C-suite
January 22, 2024HME News Staff
CARLSBAD, Calif. - Advanced Diabetes Supply, a distributor of specialized diabetes devices under the ADS and USMED brands, has made three new C-suite appointments.
The company has named Sean Muiz as chief supply chain officer, Melanie Montero as revenue cycle leader and Walt Meffert as chief transformation officer.
“We are pleased to welcome these seasoned leaders to the ADS executive team,” said Bill Mixon, who was named ADS CEO last year. “Their experience, expertise...
ADS gets ‘new eyes and ears’ to reach next phase of growth
August 2, 2023Theresa Flaherty, Managing Editor
CARLSBAD, Calif. – Advanced Diabetes Supply has never been in a stronger position for growth, company officials say, and with new CEO Bill Mixon at the helm, they’re confident about its future.
Leading ADS, a national distributor of specialty diabetes supplies, seems like a sharp divergence from Mixon's previous role leading National Seating & Mobility, a provider of complex rehab technology, but he says the two product categories have similar foundations.
“At...
In brief: ADS taps Bill Mixon as CEO, Coloplast buys Kerecis
July 12, 2023HME News Staff
CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.
The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.
“Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...
ADS names Bill Mixon CEO
July 11, 2023HME News Staff
CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.
The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.
“Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...
Inogen temporarily halts manufacturing at some locations
January 12, 2022HME News Staff
GOLETA, Calif. – Inogen says its revenues are expected to increase for the fourth quarter of 2021, but a chip shortage has forced the company to temporarily suspend manufacturing operations at its Texas and California locations.
Inogen doesn’t expect to furlough any employees as a result of the suspension, as the company currently anticipates restarting manufacturing at all locations around mid- to late February 2022 based on the information available to date.
For the...
Advanced Diabetes sees complement in US MED
August 20, 2021Theresa Flaherty, Managing Editor
CARLSBAD, Calif. – Advanced Diabetes Supply increases its visibility in the eastern U.S. and gains a large platform on which to grow with its recent acquisition of US Medical Supply (US MED).
“Both companies have a good brand, and they really complement each other,” said Tim Cady, president of ADS. “Our immediate plan, short term, is to keep both brands out there.”
ADS’s focus on insulin pumps and continuous glucose monitors – a shift forced...
In brief: CMS exempts accessories, Advanced Diabetes buys US MED, FDA classifies Philips recall
July 30, 2021HME News Staff
WASHINGTON – CMS in a final rule issued July 29 says it will permanently stop applying competitive bidding pricing to accessories for complex rehab manual wheelchairs.
In late June, CMS agreed to extend an 18-month pause on applying bid pricing to these accessories for an additional 90 days, until Oct. 1., to give the agency more time to review the industry’s request.
“We are sincerely grateful to CMS for making today’s policy decision and protecting...